Maxkos Pharmaceuticals Private Limited - Company Profile

It is a chemicals private limited company based in Solapur, Maharashtra, India, established in 2007.
2007 Solapur, Maharashtra, India Active
Last Updated:
Access Report
About Maxkos Pharmaceuticals Private Limited

Maxkos Pharmaceuticals Private Limited, a active private limited company, was established on 24 April 2007 in Solapur, Maharashtra, India. Engaging in chemical products within the manufacturing sector, it holds CIN: U24239PN2007PTC130031. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.36 M.

Formerly known as Maxkos Pharmaceuticals & Softwares Private Limited. It upholds a compliant status. Its leadership includes Uma Kashinath Patil (Director), Kashinath Dhondu Patil (Director). Its latest AGM occurred on 17 September 2025, with the balance sheet filed on 31 March 2025. It is based at 116, Industrial Estate, Hotgi Road,, Solapur, Maharashtra, 413003.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239PN2007PTC130031

  • Registration Number

    130031

  • Incorporation Date

    24 April 2007

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.36 M

  • ROC Code

    Roc Pune

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.36 M
  • Company Age 18 Year, 10 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** 55.07%
  • Profit Growth **** 218.03%
  • Ebitda **** 254.61%
  • Net Worth -13.82%
  • Total Assets **** 2.37%
Company report

Maxkos Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Maxkos Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Maxkos Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Uma Kashinath Patil Director 24 Apr 2007 Current
Kashinath Dhondu Patil Director 24 Apr 2007 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Maxkos Pharmaceuticals.

Maxkos Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 55.07% increase. The company also saw a substantial improvement in profitability, with a 218.03% increase in profit. The company's net worth observed a substantial decline by a decrease of 13.82%.

Maxkos Pharmaceuticals revenue growth over time
Maxkos Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 55.07%
*******
*******
*******
*******
Revenue from Operations
*******
 42.33%
*******
*******
*******
*******
Total Assets
*******
 2.37%
*******
*******
*******
*******
Profit or Loss
*******
 218.03%
*******
*******
*******
*******
Net Worth
*******
 -13.82%
*******
*******
*******
*******
EBITDA
*******
 254.61%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Maxkos Pharmaceuticals?

In 2017, Maxkos Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Maxkos Pharmaceuticals?

Unlock and access historical data on people associated with Maxkos Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Maxkos Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maxkos Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Maxkos Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Maxkos Pharmaceuticals Private Limited last Annual general meeting of members was held on 17 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Maxkos Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune. was documented.

  • Director Appointment

    The activity Uma Kashinath Patil was appointed as a Director was appointed as a Director on 24 Apr 2007 & has been associated with this company since 18 years 10 months . was completed.

  • Director Appointment

    The activity Kashinath Dhondu Patil was appointed as a Director was appointed as a Director on 24 Apr 2007 & has been associated with this company since 18 years 10 months . was completed.

  • Company Incorporation

    Maxkos Pharmaceuticals Private Limited was registered on 24 Apr 2007 with Roc Pune & aged 18 years 10 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Maxkos Pharmaceuticals Private Limited?

The CIN of Maxkos Pharmaceuticals Private Limited is U24239PN2007PTC130031.

Where is Maxkos Pharmaceuticals Private Limited headquartered?

Maxkos Pharmaceuticals Private Limited is headquartered at 116, Industrial Estate, Hotgi Road,, Solapur, Maharashtra, 413003.

When was Maxkos Pharmaceuticals Private Limited incorporated?

Maxkos Pharmaceuticals Private Limited was incorporated on 24 April 2007.

Who are the current directors of Maxkos Pharmaceuticals Private Limited?

The current directors of Maxkos Pharmaceuticals Private Limited are

What is the primary industry of Maxkos Pharmaceuticals Private Limited?

The primary industry of Maxkos Pharmaceuticals Private Limited is Manufacturing.

Is Maxkos Pharmaceuticals Private Limited a listed company?

Maxkos Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Maxkos Pharmaceuticals Private Limited?

The authorized capital of Maxkos Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.36 M.

What is the compliance status of Maxkos Pharmaceuticals Private Limited?

The compliance status of Maxkos Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available